Sunil Sreedharan

400 total citations
7 papers, 335 citations indexed

About

Sunil Sreedharan is a scholar working on Oncology, Genetics and Biotechnology. According to data from OpenAlex, Sunil Sreedharan has authored 7 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Genetics and 2 papers in Biotechnology. Recurrent topics in Sunil Sreedharan's work include Virus-based gene therapy research (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Research and Treatments (2 papers). Sunil Sreedharan is often cited by papers focused on Virus-based gene therapy research (3 papers), Cancer-related Molecular Pathways (3 papers) and Cancer Research and Treatments (2 papers). Sunil Sreedharan collaborates with scholars based in United States, Georgia and United Kingdom. Sunil Sreedharan's co-authors include Frank H. Valone, Abdul N. Hamood, Kendra P. Rumbaugh, John Griswold, Anish Bhatnagar, Chase Watters, Tony Reid, Harold Keer, Bert L. Lum and Frank A. Scappaticci and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Sunil Sreedharan

7 papers receiving 329 citations

Peers

Countries citing papers authored by Sunil Sreedharan

Since Specialization

Citations

This map shows the geographic impact of Sunil Sreedharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Sreedharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Sreedharan more than expected).

Fields of papers citing papers by Sunil Sreedharan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunil Sreedharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Sreedharan. The network helps show where Sunil Sreedharan may publish in the future.

Co-authorship network of co-authors of Sunil Sreedharan

This figure shows the co-authorship network connecting the top 25 collaborators of Sunil Sreedharan. A scholar is included among the top collaborators of Sunil Sreedharan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sunil Sreedharan. Sunil Sreedharan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Gallium Maltolate Treatment EradicatesPseudomonas aeruginosaInfection in Thermally Injured Mice 2009 ·Antimicrobial Agents and Chemotherapy ·(unknown), (unknown), Chase Watters, Abdul N. Hamood, John Griswold, Sunil Sreedharan, Kendra P. Rumbaugh	96
2	Retinoblastoma RB94 Enhances Radiation Treatment of Head and Neck Squamous Cell Carcinoma 2008 ·Clinical Cancer Research ·Koji Araki, (unknown), Guoyan Li, David A. Bray, Koichiro Saito, (unknown), (unknown), Sunil Sreedharan, Bert W. O’Malley, Daqing Li	14
3	Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer 2005 ·Annals of Oncology ·Geoff Chong, Anish Bhatnagar, David Cunningham, (unknown), Peter Harper, William P. Steward, John Bridgewater, Malcolm J. Moore, J Cassidy, Robert E. Coleman, Fareeda Y. Coxon, Charles H. Redfern, J Jones, Robert D. Hawkins, Donald W. Northfelt, Sunil Sreedharan, Frank H. Valone, J Carmichael	26
4	Phase II trial of the histone deacetylase inhibitor pivaloyloxymethyl butyrate (Pivanex, AN-9) in advanced non-small cell lung cancer 2004 ·Lung Cancer ·Tony Reid, Frank H. Valone, (unknown), David Irwin, (unknown), (unknown), Sunil Sreedharan, Harold Keer, Bert L. Lum, Frank A. Scappaticci, Anish Bhatnagar	138
5	Adenovirus-Mediated Retinoblastoma 94 Gene Transfer Induces Human Pancreatic Tumor Regression in a Mouse Xenograft Model 2004 ·Clinical Cancer Research ·Josep Roig, Miguel Ángel Molina‐Vila, Anna Cascante, Joaquim Calbó, Neus Carbó, (unknown), Sunil Sreedharan, Cristina Fillat, Adela Mazo	11
6	Dendritic Cells Pulsed with an Anti-Idiotype Antibody Mimicking Carcinoembryonic Antigen (CEA) Can Reverse Immunological Tolerance to CEA and Induce Antitumor Immunity in CEA Transgenic Mice 2004 ·Cancer Research ·Asim Saha, Sunil K. Chatterjee, Kenneth A. Foon, F. James Primus, Sunil Sreedharan, (unknown), Malaya Bhattacharya‐Chatterjee	32
7	The role of adenovirus-mediated retinoblastoma 94 in the treatment of head and neck cancer. 2002 ·PubMed ·Daqing Li, (unknown), (unknown), (unknown), (unknown), Ming Guo, Yun Xu, Sunil Sreedharan, Bert W. O’Malley	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact